Introduction of cationic virosome derived from vesicular stomatitis virus as a novel gene delivery system for sf9 cells-Reference-Cited by-同舟云学术

Introduction of cationic virosome derived from vesicular stomatitis virus as a novel gene delivery system for sf9 cells

Published:2016-03-16 Issue:2 Volume:27 Page:83-89
ISSN:0898-2104
Container-title:Journal of Liposome Research
language:en
Short-container-title:Journal of Liposome Research

Author:

Mohammadzadeh Yahya¹,Gholami Shima¹,Rasouli Narges¹,Sarrafzadeh Sahar¹,Seyed Tabib Nasim Sadat¹,Samiee Aref Mohammad Hasan¹,Abdoli Asghar²,Biglari Peyvand¹,Fotouhi Fatemeh¹,Farahmand Behrokh¹,Tavassoti Kheiri Masoumeh¹,Jamali Abbas¹

Affiliation:

1. Influenza Research Laboratory, Department of Virology and

2. Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.3109/08982104.2016.1144205

Reference32 articles.

1. Enhanced Gene Transfer with Fusogenic Liposomes Containing Vesicular Stomatitis Virus G Glycoprotein

2. A new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathway

3. Transient expression of DNA after ballistic introduction intoDrosophilaembryos

4. Membrane Recognition by Vesicular Stomatitis Virus Involves Enthalpy-Driven Protein-Lipid Interactions

5. A gene delivery system for insect cells mediated by arginine-rich cell-penetrating peptides

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virosome: A vector in vaccine delivery;BIO Web of Conferences;2024

2. Potentialities of nanomedicine and nanocarriers for infectious disease treatment;Nanotechnology for Drug Delivery and Pharmaceuticals;2023

3. Cell-free protein synthesis of influenza virus hemagglutinin HA2-integrated virosomes for siRNA delivery;International Journal of Pharmaceutics;2022-07

4. In Utero Electroporation for Manipulation of Specific Neuronal Populations;Membranes;2022-05-11

5. Targeted Delivery of CRISPR/Cas13 as a Promising Therapeutic Approach to Treat SARS-CoV-2;Current Pharmaceutical Biotechnology;2021-06-17